MedTrace Logo

Tranexamic Acid : Nebulization vs IV Route for Hemoptysis

NCT07212452 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2025-11-28

No results posted yet for this study

Summary

This study compares the effect of tranexamic acid on hemoptysis when given through the conventional IV route and Through nebulization.

Conditions

  • Hemoptysis
  • NEBULIZATION
  • Tranexamic Acid

Interventions

DRUG

Tranexamic Acid (TXA)

In this study we are comparing the effect of tranexamic acid on hemoptysis when given through IV route and nebulization

Sponsors & Collaborators

  • University of Health Sciences Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07212452 on ClinicalTrials.gov